Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19
David Gómez-Ríos, Víctor A. López-Agudelo, Howard Ramírez-Malule
DOI: 10.7324/JAPS.2020.10501Pages: 001-009
Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19
Manish Dhawan, Manisha Parmar, Khan Sharun, Ruchi Tiwari, Muhammad Bilal, Kuldeep Dhama
DOI: 10.7324/JAPS.2021.110402Pages: 006-013
Immunoinformatics approach in designing SARS-CoV-2 vaccine from experimentally determined SARS-CoV T-cell epitopes
Leana Rich De Mesa Herrera
DOI: 10.7324/JAPS.2021.110303Pages: 029-036
Formulation rationale for the development of SARS-COV-2 immunochromatography rapid test kits in India
Prince Manta, Raveen Chauhan, Himanshu Gandhi, Shikha Mahant, Deepak N. Kapoor
DOI: 10.7324/JAPS.2021.1101017Pages: 128-133
Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19—A narrative review
Manish Dhawan, Kuldeep Dhama, Manisha Parmar, Alisha Sharma, Steffy Angural
DOI: 10.7324/JAPS.2021.1101104Pages: 026–033
Safety, efficacy, and immunogenicity of COVAXIN: A review
Mukhtar Ahmad Dar, Priyadarshani Chauhan, Pawan Kumar, Richa Chauhan, Krishna Murti, Jaykaran Charan, Velayutham Ravichandiran, Sameer Dhingra
DOI: 10.7324/JAPS.2021.1101103Pages: 018-025
Utilization of physical and chemical microbial load reduction agents for SARS-CoV-2: Toxicity and development of drug resistance implications
Sani Yahaya Najib, Yusuf Oloruntoyin Ayipo, Abubakar Shaaban, Mohd Nizam Mordi, Abdullahi Rabiu Abubakar, Adekunle Babajide Rowaiye, Sayeeda Rahman, Rahnuma Ahmad, Bushra Ayat Meghla, Nihad Adnan, Mainul Haque
DOI: 10.7324/JAPS.2021.120101Pages: 001-028
Variations from SARS-CoV-2 to Omicron: A new threat knocking at World’s door
Acharya Balkrishna, Akansha Rohela, Ashwani Kumar, Vedpriya Arya, Nazam Khan
DOI: 10.7324/JAPS.2022.120404Pages: 037-043
In silico prediction of interactions and molecular dynamics simulation analysis of Mpro of Severe Acute Respiratory Syndrome caused by novel coronavirus 2 with the FDA-approved nonprotein antiviral drugs
Subramaniam Sivakumar, Sugumar Mohanasundaram, Narasimhan Rangarajan, Venkatesan Sampath, Maderi Velayutham Dass Prakash
DOI: 10.7324/JAPS.2022.120508Pages: 104-119
Characterization in silico of bioactive compound in tea plant as a potentials inhibitor of SARS-CoV-2 Mpro
Mohamad Endy Yulianto, Ari Yuniastuti, Dadan Rohdiana, Vita Paramita, Hermawan Dwi Ariyanto, Rizka Amalia, Sutrisno Sutrisno, Indah Hartati, Shabri Shabri, Retno Dwi Nyamiati, Siti Rahmawati
DOI: 10.7324/JAPS.2022.120909Pages: 076-085
Strong anti-SARS-CoV-2 activity of Lucilia cuprina maggots’ excretion/secretion and its effect on viral entry and notch pathway in vitro: First work
Mohammad R. K. Abdel-Samad, Fatma A. Taher, Mahmoud Shehata, Noura M. Abo Shama, Ahmed Mostafa, Mohamed A. Ali, Iman H. Ibrahim
DOI: 10.7324/JAPS.2022.120713Pages: 122-130
The role of influenza vaccination in the COVID-19 infection: Impact on incidence and severity in Iraq
Ahmed Mohammed Taqi Al Mosawi, Haitham Mahmood Kadhim, Hussam Majeed Hameed
DOI: 10.7324/JAPS.2022.120813Pages: 130-136
Seroprevalence of SARS-CoV-2 antibodies among Jordanian citizens: A cross-sectional study of the demographic and clinical factors that ameliorate serum IgG concentration
Walid Abu Rayyan
DOI: 10.7324/JAPS.2022.121116Pages: 151-156
.webp)
Adverse events associated with COVID-19 treatment and their possible relationship with patient characteristics: A narrative review
Omar Yahya Al-Shargi, Samah Mukhlef Alzaid, Bodoor Saud Al-Dosari, Abeer Saad Alzubaidi
DOI: 10.7324/JAPS.2023.105521Pages: 041-049
Identification of potential bioactive compounds from Azadirachta indica (Neem) as inhibitors of SARS-CoV-2 main protease: Molecular docking and molecular dynamics simulation studies
Donny Ramadhan, Firdayani Firdayani, Nihayatul Karimah, Elpri Eka Permadi, Sjaikhurrizal El Muttaqien, Agus Supriyono
DOI: 10.7324/JAPS.2023.139799Pages: 040-049
Molecular modeling of lupeol for antiviral activity and cellular effects
P. B. Lalthanpuii, C. Lalrinmawia, B. Lalruatfela, Lal Ramliana, K. Lalchhandama
DOI: 10.7324/JAPS.2023.145048Pages: 131-143
Mapping T-cell furin cleavage site epitopes in SARS-CoV-2 spike protein sequences from the Philippines and global variants
Maria Crischen Perono, Jewel Pasion, John Sylvester Nas, Francisco III Heralde
DOI: 10.7324/JAPS.2024.150608Pages: 197-211
Computer-aided drug design of novel nirmatrelvir analogs inhibiting main protease of Coronavirus SARS-CoV-2
Kateryna O. Lohachova, Anastasiia S. Sviatenko, Alexander Kyrychenko, Volodymyr V. Ivanov, Tierry Langer, Sergiy M. Kovalenko, Oleg N. Kalugin
DOI: 10.7324/JAPS.2024.158114Pages: 232-239
In silico screening and identification of lead molecules from Garcinia gummi-gutta with multitarget activity against SARS-CoV-2
Keerthi J. Sugathan, Sivanandan Sreekumar, Biju Charuvila Kamalan
DOI: 10.7324/JAPS.2024.150413Pages: 124-132
